0.4586
price down icon0.11%   -0.0005
pre-market  Pre-mercato:  .49   0.0314   +6.85%
loading
Precedente Chiudi:
$0.4591
Aprire:
$0.45
Volume 24 ore:
279.16K
Relative Volume:
0.16
Capitalizzazione di mercato:
$21.08M
Reddito:
$16.77M
Utile/perdita netta:
$-11.87M
Rapporto P/E:
-0.9671
EPS:
-0.4742
Flusso di cassa netto:
$-5.90M
1 W Prestazione:
-0.43%
1M Prestazione:
+27.42%
6M Prestazione:
+8.78%
1 anno Prestazione:
-64.17%
Intervallo 1D:
Value
$0.45
$0.4749
Intervallo di 1 settimana:
Value
$0.4294
$0.4879
Portata 52W:
Value
$0.30
$1.36

Immunoprecise Antibodies Ltd Stock (IPA) Company Profile

Name
Nome
Immunoprecise Antibodies Ltd
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
101
Name
Cinguettio
Name
Prossima data di guadagno
2024-09-16
Name
Ultimi documenti SEC
Name
IPA's Discussions on Twitter

Confronta IPA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
IPA
Immunoprecise Antibodies Ltd
0.4586 21.08M 16.77M -11.87M -5.90M -0.4742
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.19 127.64B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
603.58 65.95B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
656.65 37.92B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
273.55 32.98B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
254.16 26.92B 3.81B -644.79M -669.77M -6.24

Immunoprecise Antibodies Ltd Stock (IPA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-12-02 Iniziato H.C. Wainwright Buy
2021-10-25 Iniziato The Benchmark Company Buy

Immunoprecise Antibodies Ltd Borsa (IPA) Ultime notizie

pulisher
May 04, 2025

ImmunoPrecise Antibodies Ltd.'s (NASDAQ:IPA) Shares Leap 28% Yet They're Still Not Telling The Full Story - simplywall.st

May 04, 2025
pulisher
Apr 25, 2025

How ImmunoPrecise Antibodies ($IPA) Uses AI to Transform Antibody-Based Drug Discovery - Podomatic

Apr 25, 2025
pulisher
Apr 24, 2025

Views of Wall Street’s Leading Experts on ImmunoPrecise Antibodies Ltd - Sete News

Apr 24, 2025
pulisher
Apr 24, 2025

ImmunoPrecise Antibodies (OTCMKTS:IPATF) Trading Down 7% – Should You Sell? - Defense World

Apr 24, 2025
pulisher
Apr 23, 2025

What is going on with ImmunoPrecise Antibodies Ltd? Sentiment Analysis - uspostnews.com

Apr 23, 2025
pulisher
Apr 22, 2025

Will ImmunoPrecise Antibodies (NASDAQ:IPA) Spend Its Cash Wisely? - simplywall.st

Apr 22, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

H.C. Wainwright sets $50 target for ImmunoPrecise stock By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

ImmunoPrecise Antibodies’ (IPA) “Buy” Rating Reiterated at HC Wainwright - Defense World

Apr 14, 2025
pulisher
Apr 12, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI- - GuruFocus

Apr 12, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSai™ with FDA's Shift to Non-Animal Testing Methods - 01net

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Aligns with FDA’s Move to Non-Animal Testing - TipRanks

Apr 11, 2025
pulisher
Apr 11, 2025

ImmunoPrecise Antibodies Highlights Alignment of Proprietary AI-Driven Platform LENSaitm with FDA's Shift to Non-Animal Testing Methods - Lelezard

Apr 11, 2025
pulisher
Apr 11, 2025

AI Breakthrough: How IPA's LENSai Platform Leads FDA's Historic Shift from Animal Testing - Stock Titan

Apr 11, 2025
pulisher
Apr 10, 2025

ImmunoPrecise Antibodies Partners with RIBOPRO to Enhance Antibody Discovery - TipRanks

Apr 10, 2025
pulisher
Apr 04, 2025

HC Wainwright Has Positive Outlook of IPA FY2025 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

ImmunoPrecise Antibodies (IPA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Apr 03, 2025
pulisher
Apr 03, 2025

HC Wainwright Has Bearish Forecast for IPA FY2028 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

ImmunoPrecise Antibodies’ (IPA) “Speculative Buy” Rating Reaffirmed at Benchmark - Defense World

Apr 02, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Benchmark maintains Speculative Buy on Immunoprecise stock - Investing.com

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2025
pulisher
Apr 01, 2025

ImmunoPrecise Antibodies (NASDAQ:IPA) Price Target Lowered to $5.00 at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

ImmunoPrecise Antibodies Earnings Call Highlights Growth - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Immunoprecise stock target cut to $5 by H.C. Wainwright - Investing.com Australia

Mar 31, 2025
pulisher
Mar 30, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q3 Loss, Misses Revenue Estimates - MSN

Mar 30, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... By GuruFocus - Investing.com Canada

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlights: Strategic Partnerships and ... - Yahoo

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Ltd (IPA) Q3 2025 Earnings Call Highlig - GuruFocus

Mar 29, 2025
pulisher
Mar 29, 2025

ImmunoPrecise Antibodies Third Quarter 2025 Earnings: CA$0.66 loss per share (vs CA$0.11 loss in 3Q 2024) - Yahoo

Mar 29, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies Reports Q3 FY25 Financial Results - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2025 - 01net

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies Ltd reports results for the quarter ended January 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Immunoprecise Antibodies (IPA) Reports Financial Results And Recent Business Highlights For Third Quarter Fiscal Year 2025 - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

IMMUNOPRECISE ANTIBODIES Earnings Results: $IPA Reports Quarterly Earnings - Nasdaq

Mar 28, 2025
pulisher
Mar 28, 2025

ImmunoPrecise Secures Game-Changing $10M Deal as AI Division Reports 132% Growth - Stock Titan

Mar 28, 2025
pulisher
Mar 27, 2025

A Look Ahead: ImmunoPrecise Antibodies's Earnings Forecast - Benzinga

Mar 27, 2025
pulisher
Mar 26, 2025

IMMUNOPRECISE ANTIBODIES Earnings Preview: Recent $IPA Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 26, 2025
pulisher
Mar 26, 2025

Immunoprecise Antibodies Ltd expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Mar 26, 2025
pulisher
Mar 22, 2025

Mason Hill Advisors buying at Ascot Resources (AOT) - The Globe and Mail

Mar 22, 2025
pulisher
Mar 21, 2025

ImmunoPrecise Antibodies (IPA) to Release Quarterly Earnings on Friday - Defense World

Mar 21, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies Ltd. (IPA) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 17, 2025
pulisher
Mar 17, 2025

ImmunoPrecise Antibodies’ (IPA) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 17, 2025
pulisher
Mar 13, 2025

ImmunoPrecise partners for cancer drug advancement By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

What's Going On With ImmunoPrecise Stock Thursday?ImmunoPrecise Antibodies (NASDAQ:IPA) - Benzinga

Mar 13, 2025
pulisher
Mar 13, 2025

ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics. - 01Net

Mar 13, 2025
pulisher
Mar 13, 2025

Sector Update: Health Care -March 13, 2025 at 08:52 am EDT - Marketscreener.com

Mar 13, 2025

Immunoprecise Antibodies Ltd Azioni (IPA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
Capitalizzazione:     |  Volume (24 ore):